Combined Treatment With Chondroitin Sulfate and Glucosamine Sulfate Shows No Superiority Over Placebo for Reduction of Joint Pain and Functional Impairment in Patients With Knee Osteoarthritis: A Six-Month Multicenter, Randomized, Double-Blind, Placebo-Co

Effects of glucosamine sulfate on the use of rescue non-steroidal anti-inflammatory drugs in knee osteoarthritis: Results from the Pharmaco-Epidemiology of GonArthroSis (PEGASus) study

(2016) Lucio C. Rovati et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Comparative Effectiveness of Pharmacologic Interventions for Knee Osteoarthritis

(2015) Raveendhara R. Bannuru et al.   ANNALS OF INTERNAL MEDICINE

Placebos for Knee Osteoarthritis: Reaffirmation of “Needle Is Better Than Pill”

(2015) Weiya Zhang et al.   ANNALS OF INTERNAL MEDICINE

Does MOVES move the needle?

(2015) Robert Meyer   ANNALS OF THE RHEUMATIC DISEASES

Is chondroitin sulfate plus glucosamine superior to placebo in the treatment of knee osteoarthritis?

(2015) Chao Zeng et al.   ANNALS OF THE RHEUMATIC DISEASES

Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a multicentre, randomised, double-blind, non-inferiority trial versus celecoxib

(2015) Marc C Hochberg et al.   ANNALS OF THE RHEUMATIC DISEASES

Recommendations for an update of the 2010 European regulatory guideline on clinical investigation of medicinal products used in the treatment of osteoarthritis and reflections about related clinically relevant outcomes: expert consensus statement

(2015) J.-Y. Reginster et al.   OSTEOARTHRITIS AND CARTILAGE

Effects of Glucosamine and Chondroitin Supplementation on Knee Osteoarthritis: An Analysis With Marginal Structural Models

(2015) Shibing Yang et al.   Arthritis & Rheumatology

Glucosamine and chondroitin for knee osteoarthritis: a double-blind randomised placebo-controlled clinical trial evaluating single and combination regimens

(2014) Marlene Fransen et al.   ANNALS OF THE RHEUMATIC DISEASES

OARSI guidelines for the non-surgical management of knee osteoarthritis

(2014) T.E. McAlindon et al.   OSTEOARTHRITIS AND CARTILAGE

Absorption, distribution and mechanism of action of SYSADOAS

(2014) Patrick du Souich   PHARMACOLOGY & THERAPEUTICS

An algorithm recommendation for the management of knee osteoarthritis in Europe and internationally: A report from a task force of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)

(2014) Olivier Bruyère et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Risk of Bias and Brand Explain the Observed Inconsistency in Trials on Glucosamine for Symptomatic Relief of Osteoarthritis: A Meta-Analysis of Placebo-Controlled Trials

(2014) Patrick Eriksen et al.   ARTHRITIS CARE & RESEARCH

First-line analysis of the effects of treatment on progression of structural changes in knee osteoarthritis over 24 months: data from the osteoarthritis initiative progression cohort

(2013) Johanne Martel-Pelletier et al.   ANNALS OF THE RHEUMATIC DISEASES

EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis

(2013) Linda Fernandes et al.   ANNALS OF THE RHEUMATIC DISEASES

Chondroitin and Glucosamine in the Management of Osteoarthritis: An Update

(2013) Yves Henrotin et al.   Current Rheumatology Reports

Equivalence of a single dose (1200 mg) compared to a three-time a day dose (400 mg) of chondroitin 4&6 sulfate in patients with knee osteoarthritis. Results of a randomized double blind placebo controlled study

(2012) B. Zegels et al.   OSTEOARTHRITIS AND CARTILAGE

American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee

(2012) Marc C. Hochberg et al.   ARTHRITIS CARE & RESEARCH

Therapeutic trajectory following intra-articular hyaluronic acid injection in knee osteoarthritis – meta-analysis

(2011) R.R. Bannuru et al.   OSTEOARTHRITIS AND CARTILAGE

Clinical efficacy and safety of glucosamine, chondroitin sulphate, their combination, celecoxib or placebo taken to treat osteoarthritis of the knee: 2-year results from GAIT

(2010) A. D. Sawitzke et al.   ANNALS OF THE RHEUMATIC DISEASES

The “placebo” response in osteoarthritis and its implications for clinical practice

(2009) M. Doherty et al.   OSTEOARTHRITIS AND CARTILAGE

The human pharmacokinetics of oral ingestion of glucosamine and chondroitin sulfate taken separately or in combination

(2009) C.G. Jackson et al.   OSTEOARTHRITIS AND CARTILAGE

The placebo effect and its determinants in osteoarthritis: meta-analysis of randomised controlled trials

(2008) W Zhang et al.   ANNALS OF THE RHEUMATIC DISEASES

The effect of glucosamine and/or chondroitin sulfate on the progression of knee osteoarthritis: A report from the glucosamine/chondroitin arthritis intervention trial

(2008) Allen D. Sawitzke et al.   ARTHRITIS AND RHEUMATISM